Suppr超能文献

样本药柜中的药物既不新颖也没有用。

Sample closet medications are neither novel nor useful.

机构信息

Department of Family and Community Medicine, University of Arizona College of Medicine, Phoenix, USA.

出版信息

J Am Board Fam Med. 2013 Jul-Aug;26(4):380-7. doi: 10.3122/jabfm.2013.04.120330.

Abstract

BACKGROUND

Many physicians dispense drug samples in their offices, but this practice may not benefit patients. We analyzed the novelty and usefulness of the medications most commonly found in sample closets in primary care practices.

METHODS

In this cross-sectional study, we inventoried 10 sample closets from internal medicine and family practice offices in the Phoenix metropolitan area. We analyzed 23 medications found in 7 or more closets. To assess novelty, we determined whether the sample medication had a new mechanism of action, a generic version with the same mechanism of action on the market, and a generic medication for the same indication on the market. To assess usefulness, we determined whether the sample medication improved patient-oriented outcomes, safety, and tolerability. We noted the cost of a 1-month supply for a typical starting dose.

RESULTS

Ninety-six percent (n = 22) of sample closet medications had a generic medication for the same indication and 74% (n = 17) had a generic medication with the same mechanism available on the market. Only 3 medications (13%) had evidence of superior patient-oriented outcomes when compared with other medications for the same indication. Six medications (26%) demonstrated superior safety or tolerability. Only one medication (4%) was recommended as a first-line therapy in an evidence-based guideline. The mean cost for a 1-month supply of a typical starting dose was $178.

CONCLUSIONS

Sample closet medications have limited novelty and usefulness and are often expensive. The widespread use of sample medications should be reexamined.

摘要

背景

许多医生在自己的办公室发放药品样本,但这种做法可能对患者无益。我们分析了在初级保健实践中样本柜中最常见的药物的新颖性和有用性。

方法

在这项横断面研究中,我们对凤凰城市区的内科和家庭实践办公室的 10 个样本柜进行了盘点。我们分析了在 7 个或更多柜子中发现的 23 种药物。为了评估新颖性,我们确定了样本药物是否具有新的作用机制、具有相同作用机制的通用版本以及具有相同适应证的通用药物在市场上。为了评估有用性,我们确定了样本药物是否改善了以患者为中心的结果、安全性和耐受性。我们注意到典型起始剂量 1 个月供应量的成本。

结果

96%(n = 22)的样本柜药物有相同适应证的通用药物,74%(n = 17)有相同作用机制的通用药物在市场上。与同一适应证的其他药物相比,只有 3 种药物(13%)具有优越的以患者为中心的结果证据。6 种药物(26%)表现出更好的安全性或耐受性。只有一种药物(4%)被推荐为循证指南中的一线治疗药物。典型起始剂量 1 个月供应量的平均费用为 178 美元。

结论

样本柜药物的新颖性和有用性有限,而且往往很昂贵。应重新审查样本药物的广泛使用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验